BrainStorm Cell Therapeutics
BCLI
#10412
Rank
โ‚ฌ5.1 M
Marketcap
0,46ย โ‚ฌ
Share price
-3.57%
Change (1 day)
-76.54%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2025 (TTM): -1,32ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,28ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -5,78ย โ‚ฌ an increase over its 2014 EPS that were of -8,74ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,32ย โ‚ฌ
2015-5,78ย โ‚ฌ-33.82%
2014-8,74ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
5,59ย โ‚ฌ-537.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,39ย โ‚ฌ 322.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,43ย โ‚ฌ 169.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
9,41ย โ‚ฌ-837.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-2,66ย โ‚ฌ 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA